Family Medicine · Irvine, CA
NPI
1356366835
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
18 Endeavor, Suite 307
Irvine, CA, 92618
Phone (949) 260-0106
Groups this clinician bills Medicare through
Medicare paid, 2024
$228K
2,631 services
Medicare patients, 2024
502
Average age 75
Drug cost, 2024
$1.9M
11,870 prescriptions
Company payments, 2025
$147
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan R Nili was code 99214 (office e&m - established), 813 times for 414 patients. In total Alan R Nili billed 2,631 services in 31 codes, and Medicare paid $228K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 813 | 414 | $109.03 | $89K |
| 99213 Office E&M - Established | Office | 357 | 244 | $74.85 | $27K |
| 99497 Care Management/Coordination | Office | 271 | 271 | $67.61 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 255 | 255 | $144.39 | $37K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 250 | 250 | $21.72 | $5,429 |
| 99215 Office E&M - Established | Office | 156 | 120 | $155.03 | $24K |
| G0008 Administration of influenza virus vaccine | Office | 110 | 108 | $24.50 | $2,695 |
| 90661 Vaccine Product | Office | 98 | 98 | $36.11 | $3,539 |
| 96372 Injection Administration | Office | 61 | 42 | $12.95 | $790 |
| 93000 Electrocardiogram | Office | 36 | 35 | $12.78 | $460 |
| G0009 Administration of pneumococcal vaccine | Office | 31 | 31 | $34.30 | $1,063 |
| 90677 Vaccine Product | Office | 30 | 30 | $289.02 | $8,671 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 25 | 17 | $1.00 | $25.08 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 23 | 23 | $183.26 | $4,215 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 22 | 22 | $27.31 | $601 |
By year: 2022 $234K for 2,929 services; 2023 $242K for 2,962 services; 2024 $228K for 2,631 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan R Nili prescribed most often to Medicare patients was Rosuvastatin Calcium, with 986 prescriptions and refills. In total Alan R Nili wrote 11,870 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 986 | 2,825 | 281 | $18K |
| Atorvastatin Calcium Generic | 724 | 2,105 | 206 | $5,882 |
| Levothyroxine Sodium Generic | 434 | 1,211 | 115 | $4,560 |
| Famotidine Generic | 427 | 1,159 | 157 | $6,390 |
| Amlodipine Besylate Generic | 421 | 1,200 | 131 | $2,117 |
| Metformin Hcl Generic | 400 | 1,156 | 119 | $3,059 |
| Losartan Potassium Generic | 373 | 1,042 | 114 | $3,659 |
| Fluticasone Propionate Generic | 313 | 584 | 150 | $4,228 |
| Ezetimibe Generic | 236 | 686 | 73 | $7,289 |
| Escitalopram Oxalate Generic | 226 | 619 | 66 | $2,625 |
| Gabapentin Generic | 223 | 416 | 77 | $4,589 |
| Omeprazole Generic | 216 | 578 | 81 | $2,777 |
| Tamsulosin Hcl Generic | 204 | 532 | 67 | $3,177 |
| Metoprolol Succinate Generic | 199 | 572 | 59 | $3,086 |
| Alendronate Sodium Generic | 180 | 471 | 61 | $1,197 |
Brand drugs: 1,716 claims; generic drugs: 10,136 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan R Nili $147 ($147 in general payments such as food, travel and fees) from 1 company. The largest payer was New World Medical,Inc. with $147.
| Company | Payments | Amount |
|---|---|---|
| New World Medical,Inc. | 1 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.